Hypoxia-Inducible Factor 1 and Preeclampsia: A New Perspective

Area of Science:

• Obstetrics and Gynecology
• Perinatal Medicine
• Molecular Biology

Background:

• Preeclampsia (PE) is a significant pregnancy complication affecting 2-8% of women globally.
• PE is characterized by hypertension, proteinuria, and edema after 20 weeks of gestation.
• Placental hypoxia initiates inflammatory responses, oxidative stress, and endothelial dysfunction, contributing to PE.

Purpose of the Study:

• To explore the association between preeclampsia and hypoxia-inducible factor 1 (HIF-1) in pregnant women.
• To offer a novel perspective on the role of HIF-1 in PE development.

Main Methods:

• This is a narrative review, synthesizing existing research on HIF-1 and preeclampsia.
• Focuses on the molecular mechanisms linking HIF-1 to placental dysfunction and PE.

Main Results:

• Hypoxia-inducible factor 1 (HIF-1) is a crucial transcription factor regulating cellular responses to hypoxia.
• HIF-1α is vital for placental differentiation and function, acting as a biomarker for placental vascularization.
• HIF-1 contributes to PE pathogenesis by promoting anti-angiogenic factors, inhibiting proangiogenic factors, and activating inflammatory pathways like p38MAPK and NLRP3 inflammasomes.

Conclusions:

• HIF-1 is implicated in the pathogenesis of preeclampsia through its role in placental inflammation and dysfunction.
• HIF-1 acts as a potential molecular link between inflammatory signaling and the development of PE.
• Further research into HIF-1 pathways may reveal new therapeutic targets for preeclampsia.